For: | Au KP, Chok KSH. Immunotherapy after liver transplantation: Where are we now? World J Gastrointest Surg 2021; 13(10): 1267-1278 [PMID: 34754394 DOI: 10.4240/wjgs.v13.i10.1267] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v13/i10/1267.htm |
Number | Citing Articles |
1 |
Coskun Ozer Demirtas, Feyza Gunduz. Programmed Cell Death 1 and Hepatocellular Carcinoma: An Epochal Story. Journal of Gastrointestinal Cancer 2021; 52(4): 1217 doi: 10.1007/s12029-021-00758-z
|
2 |
Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Thomas Talbot, Alessandra Gennari, Mark R. Openshaw, Coskun O. Demirtas, Alessio Cortellini, David J. Pinato. New Frontiers in the Medical Therapy of Hepatocellular Carcinoma. Chemotherapy 2022; doi: 10.1159/000521837
|
3 |
Kathrine S Rallis, Dimitrios Makrakis, Ioannis A Ziogas, Georgios Tsoulfas. Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances. World Journal of Clinical Oncology 2022; 13(6): 448-472 doi: 10.5306/wjco.v13.i6.448
Abstract(61) |
Core Tip(48) |
Full Article(HTML)(328)
|
Full Article (PDF)-2108K(33)
|
Full Article (Word)-1006K(4)
|
Audio-355K(0)
|
Peer-Review Report-462K(8)
|
Answering Reviewers-119K(8)
|
Times Cited (0)
|
Total Visits (765)
|
Open
|
4 |
Anthony C. Bejjani, Richard S. Finn. Hepatocellular Carcinoma: Pick the Winner—Tyrosine Kinase Inhibitor Versus Immuno-oncology Agent–Based Combinations. Journal of Clinical Oncology 2022; doi: 10.1200/JCO.21.02605
|
5 |
Sai Swarupa R Vulasala, Nirmal K Onteddu, Sindhu P Kumar, Chandana Lall, Priya Bhosale, Mayur K Virarkar. Advances and effectiveness of the immunotherapy after liver transplantation. World Journal of Gastrointestinal Surgery 2022; 14(6): 629-631 doi: 10.4240/wjgs.v14.i6.629
Abstract(46) |
Core Tip(33) |
Full Article(HTML)(148)
|
Full Article (PDF)-1524K(17)
|
Full Article (Word)-103K(17)
|
Audio-296K(0)
|
Peer-Review Report-189K(8)
|
Answering Reviewers-56K(11)
|
Times Cited (0)
|
Total Visits (469)
|
Open
|